Intracameral bevacizumab role in trabeculectomy: A 1-year prospective randomized controlled study
- 9 September 2019
- journal article
- research article
- Published by SAGE Publications in European Journal of Ophthalmology
- Vol. 30 (6) , 1356-1361
Abstract
Purpose: To evaluate the effect of intracameral Bevacizumab on trabeculectomy success rates. Methods: A prospective, randomized, interventional clinical trial. Patients with primary open-angle glaucoma were randomly assigned to two groups: trabeculectomy with mitomycin C and trabeculectomy with mitomycin C and intracameral bevacizumab. Complete success is defined as an intraocular pressure (IOP) reduction of at least 30% from baseline IOP to a measured pressure of between 5 and 18 mm Hg without the use of IOP lowering medications. Qualified success is defined as same achievement of reduced IOP, but with the use of IOP lowering medications. Overall success is defined as same achievement of reduced IOP with or without the use of IOP lowering medications. Results: Thirty-three patients in the mitomycin C group and 36 patients in the mitomycin C and bevacizumab group were included in final analyses. The IOP at presentation was 28.3 ± 8 and 28.4 ± 8.6 mm Hg, compared to 10.8 ± 3.4 and 12.3 ± 3.7 mm Hg at 12 months (p < 0.0001) for the mitomycin C group and the mitomycin C and bevacizumab group, respectively. Complete success at 12 months was achieved in 65% of the mitomycin C group compared to 60% of the mitomycin C and bevacizumab group (p = 0.77). Overall success was achieved in 82% compared to 80% of patients at 12 months (p = 0.78). Both groups showed a statistically significant reduction in IOP after 6 and 12 months (p ⩽ 0.001). There were no statistically significant differences in visual acuity and complications. Conclusion: Intracameral bevacizumab during mitomycin C trabeculectomy in patients with primary open-angle glaucoma apparently does not improve success rates. The adjuvant use of intracameral bevacizumab is therefore not justified.Keywords
This publication has 30 references indexed in Scilit:
- The Effect of Bevacizumab on the Outcome of Trabeculectomy with 5-FluorouracilJournal of Ocular Pharmacology and Therapeutics, 2013
- The role of different VEGF isoforms in scar formation after glaucoma filtration surgeryExperimental Eye Research, 2011
- Intravitreal bevacizumab with or without mitomycin C trabeculectomy in the treatment of neovascular glaucomaClinical Ophthalmology, 2011
- Combined Intravitreal Bevacizumab and Trabeculectomy With Mitomycin C Versus Trabeculectomy With Mitomycin C Alone for Neovascular GlaucomaJournal of Glaucoma, 2011
- In Vitro Effects of Antivascular Endothelial Growth Factors on Cultured Human Trabecular Meshwork CellsJournal of Glaucoma, 2010
- Review of results from the Tube Versus Trabeculectomy StudyCurrent Opinion in Ophthalmology, 2010
- Subconjunctival Bevacizumab as an Adjunct to Trabeculectomy in Eyes with Refractory Glaucoma: A Case SeriesKorean Journal of Ophthalmology, 2010
- Postoperative Use of Bevacizumab as an Antifibrotic Agent in Glaucoma Filtration Surgery in the RabbitInvestigative Ophthalmology & Visual Science, 2009
- Evaluation of Subconjunctival Bevacizumab as an Adjunct to TrabeculectomyOphthalmology, 2008
- Bevacizumab in Combination With Fluorouracil and Leucovorin: An Active Regimen for First-Line Metastatic Colorectal CancerJournal of Clinical Oncology, 2005